Incyte Corporation vs Main Street Capital Corporation — how do they compare? Incyte Corporation trades at $120.45 (market cap $24.54B), while Main Street Capital Corporation trades at $59.13 (market cap $5.52B). The key difference: Incyte Corporation is far larger — about 4.4× Main Street Capital Corporation's market cap, and Main Street Capital Corporation pays a 5.39% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | MAIN | |
|---|---|---|
Market Cap | $24.54B | $5.52B |
Sector | Health | Financials |
52-Week High | $129.93 | $67.54 |
52-Week Low | $81.61 | $49.63 |
Enterprise Value | $20.04B | — |
Dividend Yield | — | 5.39% |
Trailing returns across standard periods
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →